Chien: Significant Recall of CBD Products for Dogs in France

A national recall affecting oils containing CBD and hemp extracts for dogs and cats was issued on April 1, 2026, in France. This significant action was prompted by concerns over the safety and legality of these products, which are classified as unauthorized additives for animal nutrition by the Ministry of the Economy in France.

The recall encompasses all lots of CBD and hemp-extract oils marketed for cats and dogs under the brands CBDSOL and Mama Kana. These products were sold across France between March 18, 2022, and March 19, 2026. Consumers are instructed to stop using the recalled products immediately and to return them to the point of sale or destroy them.

In light of this recall, a refund procedure for the affected products will be available until September 1, 2026. This measure aims to mitigate the impact on consumers who may have purchased these products under the impression that they were safe for their pets.

The Ministry of the Economy emphasized that such products are regulated and require proper authorization for their marketing and use. This statement underscores the seriousness of the situation, as many pet owners may have unknowingly administered these oils to their animals.

As the recall unfolds, further developments are anticipated regarding the safety of CBD and hemp extracts in the pet care market. The potential health implications for pets that may have consumed these products remain a critical concern.

Details remain unconfirmed regarding the extent of the health risks posed by the recalled products, but the urgency of the recall indicates significant caution from regulatory authorities.

In the broader context, the recall highlights ongoing debates about the use of CBD and hemp extracts in animal nutrition, especially as these products gain popularity among pet owners.

With the increasing trend of pet owners seeking natural remedies for their animals, this incident may prompt a reevaluation of regulations surrounding such products in the future.

As consumers await more information, the situation serves as a reminder of the importance of regulatory oversight in the pet care industry.